John Ragard - 30 Sep 2024 Form 4/A - Amendment Insider Report for Aspira Women's Health Inc. (AWH)

Role
Director
Signature
/s/ John Ragard
Issuer symbol
AWH
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4/A - Amendment
Filing time
22 Nov 2024, 18:16:16 UTC
Date Of Original Report
02 Oct 2024
Previous filing
26 Aug 2024
Next filing
08 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AWH Common Stock Options Exercise $0 +4,844 +4.2% $0.000000 120,203 30 Sep 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AWH Restricted Stock Units Options Exercise $0 -4,844 -25% $0.000000 14,531 30 Sep 2024 Common stock 4,844 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
F2 Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
F3 On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.
F4 This report is being filed to correct the derivative securities from acquired to disposed.